Top Markets
Coin of the day
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Rangering i aksjer #12604
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Aksjekurs
$9.09
Sist synkronisert: 2023-06-23
Markedsverdi
$567.77M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel CTI BioPharma Corp. (CTIC)

Kategori

Historikk for aksjesplitt for CTI BioPharma Corp. (CTIC)
Aksjen CTI BioPharma Corp. (symbol: CTIC) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 31, 2026.
Én CTIC-aksje kjøpt før Aug 31, 2026 tilsvarer i dag 0 CTIC-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH